NASDAQ:NAKA · NASDAQ Global Market
+$0.00 today
Vol 0.22M · Avg 0.24M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Stock Ticker Earnings Waterfall
NASDAQ:NAKA · Revenue to Net Income
Key Ratios
Analysis
$3.9M of revenue converted into -$290.0M of net income for the selected period. Gross margin is -593.4% and net margin is -5823.8%, showing how much revenue survives after costs and taxes. EPS is $-29.55, tying the income statement back to per-share earnings.
Revenue
—
Operating Income
—
Net Income
—
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.8M -33.0% | $2.7M -27.8% | $3.8M -0.5% | $3.8M +51.2% | $2.5M | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $11.1M +211.3% | $3.6M +1475.1% | $226.2K +48.4% | $152.4K -90.4% | $1.6M | $725.6M | $804.0M | $882.4M |
| Gross Profit | -$9.3M -999.8% | -$842.6K -123.8% | $3.5M -2.5% | $3.6M +297.3% | $914.9K | $8.9B | $7.6B | $6.2B |
| Gross Margin | -508.8% -477.8pp | -31.0% -125.0pp | 94.0% -2.0pp | 96.0% +59.4pp | 36.5% | 9.8% | 28.9% | 38.3% |
| Research & Development | $0 -100.0% | $377.7K +15009.2% | $2.5K | $0 | $0 | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $11.8M +516.8% | $1.9M -62.3% | $5.1M -19.4% | $6.3M +635.1% | $853.6K | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $187.9M +7402.3% | $2.5M -51.5% | $5.2M -18.4% | $6.3M +641.4% | $853.6K | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $242.0K +9.8% | $220.3K +8.4% | $203.2K +66.6% | $122.0K +92.4% | $63.4K | $374.2M | $1.2B | $631.8M |
| EBITDA | -$44.9M -1395.6% | -$3.0M -121.1% | -$1.4M +43.8% | -$2.4M -2038.9% | $124.7K | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | -2466.7% -2356.3pp | -110.4% -74.4pp | -36.0% +27.8pp | -63.9% -68.8pp | 5.0% | 5.6% | 46.3% | 42.0% |
| Operating Income | -$197.1M -5790.4% | -$3.3M -106.6% | -$1.6M +39.8% | -$2.7M -4491.0% | $61.3K | $12.3B | $14.0B | -$15.7B |
| Operating Margin | -10824.0% -10701.0pp | -123.1% -80.1pp | -43.0% +28.1pp | -71.1% -73.6pp | 2.4% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 | $0 | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $7.1M +1694.5% | $393.4K +604.5% | $55.8K | $0 | $0 | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | $144.9M +53596.9% | -$270.9K -9917.9% | $2.8K -98.2% | $152.8K +73.7% | $88.0K | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$52.2M -1343.7% | -$3.6M -123.7% | -$1.6M +36.3% | -$2.5M -1801.3% | $149.3K | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -2867.6% -2734.6pp | -133.0% -90.1pp | -42.9% +24.2pp | -67.1% -73.0pp | 6.0% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $1.3B | -$1.6B | $745.2M |
| Net Income | -$52.2M -1343.7% | -$3.6M -123.7% | -$1.6M +36.3% | -$2.5M -1801.3% | $149.3K | $4.9B | $4.8B | $4.7B |
| Net Margin | -2867.6% -2734.6pp | -133.0% -90.1pp | -42.9% +24.2pp | -67.1% -73.0pp | 6.0% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$10 -1452.2% | -$1 -148.1% | -$0 +37.2% | -$0 -1820.0% | $0 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$10 -1452.2% | -$1 -148.1% | -$0 +37.2% | -$0 -1820.0% | $0 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $11.4M +110.8% | $5.4M -8.5% | $5.9M +0.0% | $5.9M -1.4% | $6.0M | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $11.4M +110.8% | $5.4M -8.5% | $5.9M +0.0% | $5.9M -1.4% | $6.0M | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Agilon Health, Inc.
NYSE:AGL
$1.85B
Delcath Systems, Inc.
NASDAQ:DCTH
$455.69M
DBV Technologies S.A.
NASDAQ:DBVT
$378.44M
Simulations Plus, Inc.
NASDAQ:SLP
$371.58M
SOPHiA GENETICS S.A.
NASDAQ:SOPH
$367.75M
Amarin Corporation plc
NASDAQ:AMRN
$338.58M
Cellectis S.A.
NASDAQ:CLLS
$331.38M
Lyell Immunopharma, Inc.
NASDAQ:LYEL
$327.84M
Larimar Therapeutics, Inc.
NASDAQ:LRMR
$278.98M
Definitive Healthcare Corp.
NASDAQ:DH
$82.28M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does NAKA generate?
Nakamoto Inc. (NAKA) reported $1.82M of revenue in fiscal 2025.
Is NAKA profitable?
Nakamoto Inc. (NAKA) reported -$52.23M of net income, with a net margin of -2867.6%.
Explore More
Continue the stock analysis
Jump to another research area for this company.